Alice Young, Ph.D.

Positions

Current:

• Professor of Psychology and Associate Vice President for Research, TTU
• Professor of Pharmacology & Neuroscience, TTUHSC

Past:

• 1981-2004 Assistant Professor to Professor, Department of Psychology, Wayne State University
• 1996-2004 Associate Dean for Research and Graduate Programs, College of Science, Wayne State University

Professional Services:

• Associate Editor, Journal of Pharmacology and Experimental Therapeutics, 2002-2009
• Associate Editor, Behavioral Pharmacology, 2000-2002
• Editorial Advisory Boards: Behavioral Pharmacology (1989-2009)
• Experimental and Clinical Psychopharmacology (1977-2005)
• Journal of Experimental Analysis of Behavior (1999-2001, 2006-2009)
• Journal of Pharmacology and Experimental Therapeutics (1992-2009)
• Pharmacology Biochemistry and Behavior (1988-present)
• President, Division for Behavioral Pharmacology American Society for Pharmacology and Experimental Therapeutics, 2005-2007
• President, Behavioral Pharmacology Society, 2002-2004

Awards and Honors

• Outstanding Graduate Mentor Award, Wayne State University, 1997

Research

Interests:
Psychopharmacology, roles of receptor-mediated processes in development of drug tolerance and dependence, and learning and memory disorders in Alzheimer's Disease.

Support:
USPHS, Behavioral studies of opioid tolerance and dependence, National Institute on Drug Abuse: July 2002 to June 2007

Selected Research:

• Young, A. M. (1999). Addictive drugs and the brain. National Forum, 79 (4), 15-18 (Reprinted in: Goldberg, R. (2002). Taking Sides: Clashing Views on Controversial Issues in Drugs and Society (5th ed.). Guilford CT: McGraw Hill/Duskin.
• Zhang, L., Walker, E. A., Sutherland, J., & Young, A. M. (2000). Discriminative stimulus effects of two doses of fentanyl in rats: Pharmacological selectivity and effects of training dose on agonist and antagonist effects of mu opioids. Psychopharmacology, 148, 136-145.
• Walker, E. A. & Young, A. M. (2001). Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology, 154, 131-142.
• Walker, E. A., & Young, A. M. (2002). Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine. Journal of Pharmacology and Experimental Therapeutics, 302, 101-110 (Printer\'s correction, 302, 836-837).
• Steinmiller, C.L., & Young, A.M. (2008) Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats. Psychopharmacology, 195, 497-507.
• Cohen, L.M., Collins. F.L. Jr., Young, A.M., McChargue, D.E., Leffingwell, T.R., & Cook, K.L. (Eds). (2009) The Pharmacology and Treatment of Substance Abuse. New York: Routledge.
• Young, A.M., & Colpaert, F.C. (2009) Recall of learned information may rely on taking drug again (letter).Nature, 457(7229), 533.
• Evola, M., Hall, A., Wall, T., Young, A.M., & Grammas, P. (2010) Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacology Biochemistry & Behavior, 96, 181-6.

 

Reaching Interests and Activites

Psychopharmacology, substance abuse, learning, biopsychology